HHealth Read More New nanoparticle therapy overcomes T cell exhaustion in solid tumorsMarch 18, 2026 Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one…
HHealth Read More Chronic inflammation shapes cancer progression and immunotherapy responseFebruary 16, 2026 Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs,…
TTechnology Read More Silica nanomatrix enhances immunotherapy for solid tumorsDecember 31, 2025 Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of…
HHealth Read More Reprogramming camp for immune cells shows early promise for autoimmune diseasesDecember 4, 2025 Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune…
HHealth Read More Generative AI aids discovery of ISM3830’s novel scaffoldDecember 2, 2025 Casitas B-lineage lymphoma-b (CBLB) is an E3 ubiquitin–protein ligase that functions as an intracellular checkpoint and master negative…
HHealth Read More Single-cell RNA sequencing uncovers diverse CD4⁺ T-cell subtypes in pediatric lupusNovember 24, 2025 Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell…
HHealth Read More Study identifies iron dysregulation in the spleen as a driver of immune agingNovember 18, 2025 Researchers at the Technion – Israel Institute of Technology Faculty of Biology have identified a unique mechanism involved…
SScience Read More How is the FOXP3 Gene Regulated?November 17, 2025 Original story from the Gladstone Institutes (CA, USA). Fine-tuning a gene centrally involved in regulating the immune system…
TTechnology Read More Mitochondria and lysosomes work together to control regulatory T cell activationOctober 25, 2025 Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the…
HHealth Read More New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studiesSeptember 26, 2025 Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the…